Cancer invasion and tissue remodeling - cooperation of protease systems and cell types

被引:265
作者
Dano, K
Romer, J
Nielsen, BS
Bjorn, S
Pyke, C
Rygaard, J
Lund, LR
机构
[1] Rigshosp, Finsen Lab, DK-2100 Copenhagen O, Denmark
[2] Novo Nordisk AS, Hlth Care Discovery, Histol, DK-2880 Bagsvaerd, Denmark
[3] Bartholin Inst, Copenhagen, Denmark
关键词
cancer invasion; tissue remodeling; proteases; stromal cells; plasminogen; MMPs;
D O I
10.1111/j.1699-0463.1999.tb01534.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Proteolytic degradation of the extracellular matrix plays a crucial role in both cancer invasion and non-neoplastic tissue remodeling processes. In human cancers the components of matrix degrading protease systems (uPA, uPAR, PAI-1 and MMPs) can be expressed by either the non-neoplastic stromal cells, the cancer cells or both. Studies of the prognostic impact of these components in human cancer and the effect of targeted gene inactivation on cancer metastasis in mice support the assumption that proteases promote cancer progression, independent of whether they are expressed by cancer cells or stromal cells. The pattern of expression of components of protease systems is usually very similar in different cases of the same type of cancer, while it varies between different types of cancer. There are intriguing similarities between the cellular expression pattern of components of protease systems seen in cancer invasion and in certain types of non-neoplastic tissue remodeling. We propose that cancer invasion can be viewed as tissue remodeling gone out of control. The stromal cell involvement in cancer invasion represents a new paradigm with important implications for cancer pathophysiology and cancer therapy.
引用
收藏
页码:120 / 127
页数:8
相关论文
共 106 条
  • [1] Human collagenase-3 is expressed in malignant squamous epithelium of the skin
    Airola, K
    Johansson, N
    Kariniemi, AL
    Kahari, VM
    SaarialhoKere, UK
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (02) : 225 - 231
  • [2] ANDREASEN PA, 1990, MOL CELL ENDOCRINOL, V88, P1
  • [3] Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
    Bajou, K
    Noël, A
    Gerard, RD
    Masson, V
    Brunner, N
    Holst-Hansen, C
    Skobe, M
    Fusenig, NE
    Carmeliet, P
    Collen, D
    Foidart, JM
    [J]. NATURE MEDICINE, 1998, 4 (08) : 923 - 928
  • [4] Expression and regulation of collagenase-3 (MMP-13) in human malignant tumors
    Balbín, M
    Pendás, AM
    Uría, JA
    Jiménez, MG
    Freije, JP
    López-Otín, C
    [J]. APMIS, 1999, 107 (01) : 45 - 53
  • [5] EXPRESSION OF THE STROMELYSIN-3 GENE IN FIBROBLASTIC CELLS OF INVASIVE CARCINOMAS OF THE BREAST AND OTHER HUMAN TISSUES - A REVIEW
    BASSET, P
    WOLF, C
    CHAMBON, P
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1993, 24 (03) : 185 - 193
  • [6] Bateman J B, 1986, J Pediatr Ophthalmol Strabismus, V23, P137
  • [7] BEHRENDT N, 1990, J BIOL CHEM, V265, P6453
  • [8] BIANCHI E, 1994, CANCER RES, V54, P861
  • [9] UROKINASE-TYPE PLASMINOGEN-ACTIVATOR - PROENZYME, RECEPTOR, AND INHIBITORS
    BLASI, F
    VASSALLI, JD
    DANO, K
    [J]. JOURNAL OF CELL BIOLOGY, 1987, 104 (04) : 801 - 804
  • [10] Endoproteinase-protein inhibitor interactions
    Bode, W
    Fernandez-Catalan, C
    Nagase, H
    Maskos, K
    [J]. APMIS, 1999, 107 (01) : 3 - 10